BBH Holdings Information

BBH is an equity ETF with a total of 26 individual holdings. The top holdings are Amgen stock at 12.48%, Gilead Sciences at 11.82%, Vertex Pharmaceuticals at 9.32%, Regeneron Pharmaceuticals at 5.78%, and Insmed at 5.18%.

Total Holdings

Top 10 Percentage

67.13%

Asset Class

Equity

ETF Category

Health

Assets

381.09M

PE Ratio

24.08

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	12.48%	149,804
2	GILD	Gilead Sciences, Inc.	11.82%	365,275
3	VRTX	Vertex Pharmaceuticals Incorporated	9.32%	79,611
4	REGN	Regeneron Pharmaceuticals, Inc.	5.78%	29,492
5	INSM	Insmed Incorporated	5.18%	101,103
6	NTRA	Natera, Inc.	5.16%	85,049
7	ARGX	argenx SE	5.02%	21,490
8	IQV	IQVIA Holdings Inc.	4.76%	80,241
9	ONC	BeOne Medicines AG	3.81%	45,276
10	ALNY	Alnylam Pharmaceuticals, Inc.	3.78%	34,929
11	UTHR	United Therapeutics Corporation	3.59%	28,026
12	BIIB	Biogen Inc.	3.54%	78,231
13	ICLR	ICON Public Limited Company	3.17%	63,588
14	ILMN	Illumina, Inc.	3.13%	87,299
15	NBIX	Neurocrine Biosciences, Inc.	2.43%	59,749
16	EXAS	Exact Sciences Corporation	2.30%	86,353
17	INCY	Incyte Corporation	2.21%	87,392
18	BNTX	BioNTech SE	2.01%	79,789
19	MRNA	Moderna, Inc.	1.82%	234,401
20	QGEN	Qiagen N.V.	1.59%	133,013
21	TECH	Bio-Techne Corporation	1.53%	96,391
22	TEM	Tempus AI, Inc.	1.52%	78,391
23	CRL	Charles River Laboratories International, Inc.	1.43%	27,952
24	RGEN	Repligen Corporation	1.34%	31,477
25	BMRN	BioMarin Pharmaceutical Inc.	1.26%	90,885

Showing 25 of 26 holdings

Subscribe to see the full list

Activate Now

As of Dec 12, 2025